S'pore drug development gets another shot in the arm
One goal for EDDC will be to create projects that are attractive to multinational pharmaceutical companies
Singapore
A*STAR officially opened the new Experimental Drug Development Centre (EDDC) on Wednesday to take more made-in-Singapore drugs from early-stage drug discovery to clinical trials and commercialisation.
Towards this end, the statutory board also launched the Target Translation Consortium (TTC), which coordinates drug discovery efforts in academia, healthcare institutions and government agencies, and consolidated three existing A*Star grants into the Singapore Therapeutics Development Review (STDR).
TRENDING NOW
He built the Vingroup empire. Now South-east Asia’s richest man is handing some key roles to his sons
Despite the de-dollarisation debate, demand for dollar liquidity in Asia is growing
Can a first-time homebuyer couple earning S$18,000 a month afford a new EC unit?
Asia needs new energy security architecture
